Lappaconitine Hydrobromide Injection
Function and Efficacy
This product is a non-addictive analgesic with a strong analgesic effect. It also has local anesthesia, cooling, antipyretic and anti-inflammatory and detumescent effects. Compared with pethidine, this product has a similar analgesic effect, a slightly slower onset time, and a longer duration of effect; the analgesic effect is 7 times that of the antipyretic analgesic aminopyrine.
Ingredients
The main ingredients of this product and its chemical name are: The main ingredient of this product is lappaconitine hydrobromide, and its chemical name is (1α,14α,16β)-20-ethyl-1,14,16-trimethoxyaconitane-4,8,9-triol 4-[2-(acetylamino)benzoate hydrobromide monohydrate. Molecular formula: C32H44N2O8?HBr?H2O Molecular weight: 683.64
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| LAPPACONITINE HYDROBROMIDEIngredients |
A non-addictive analgesic with strong analgesic, local anesthesia, cooling, antipyretic, anti-inflammatory and detumescent effects. Its analgesic effect is comparable to that of pethidine, but with a slightly slower onset and longer duration of action; its analgesic effect is 7 times that of the antipyretic analgesic aminopyrine. More |
97792-45-5 | 3 |
Appearance
This product is a colorless clear liquid.
Indication
Used for moderate to severe pain.
Usage and Dosage
Intramuscular injection: 4 mg (1 vial) once, 1-2 times a day, or as directed by a doctor. Intravenous drip: 4-8 mg (1-2 vials) a day, dissolved in 500 ml of glucose and sodium chloride injection and dripped intravenously.
Adverse Reactions
Some patients experienced urticaria, palpitations, chest tightness, dizziness, etc., which disappeared quickly after stopping the drug.
Precautions
Not yet clear.
Special Population Medication
Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: This experiment has not been conducted and there is no reliable reference. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.
Drug Interactions
It is not clear yet.
Storage
Keep away from light and sealed.
Packaging Specification
2ml:4mg
Validity Period
24 months
Manufacturer
Harbin Pharm. Group Sanjing Pharmaceutical Co., Ltd.
-
Founded in:
2015-03-13 -
Address:
No. 76, Hengshan Road, Nangang Central District, Harbin Economic Development Zone -
Tax NO.:
91230199301153895D -
Registered Funds:
50 million yuan -
Website:
-
Email: